Advancements in Biologics Manufacturing: Biopharmaceutical CMO Market Targets USD 79.77 Billion by 2030
Biopharmaceutical CMO Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030.
This impressive surge is driven by a confluence of factors, including:
Rising demand for biologics and complex therapies: The increasing prevalence of chronic diseases and the development of...
0 Comments
0 Shares
1822 Views